APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diagnostic Radioisotopes Market Outlook and Growth Opportunities 2026

20 December 2025193 pages

Choose your research edition.

Industry ResearchDiagnostic Radioisotopes Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Radioisotopes Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Diagnostic Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Radioisotopes Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Radioisotopes Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Diagnostic Radioisotopes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diagnostic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diagnostic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diagnostic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diagnostic Radioisotopes market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diagnostic Radioisotopes market include China Isotope & Radiation, Novartis, Eli Lilly, Dongcheng, SIEMENS, Lantheus, Jubilant Pharma, GE Healthcare and Curium Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diagnostic Radioisotopes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diagnostic Radioisotopes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diagnostic Radioisotopes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diagnostic Radioisotopes market size, projected growth trends, production technologies, key applications, and end-use industries.

Diagnostic Radioisotopes Segment by Company

China Isotope & Radiation

Novartis

Eli Lilly

Dongcheng

SIEMENS

Lantheus

Jubilant Pharma

GE Healthcare

Curium Pharma

Cardinal Health

Bracco Imaging

Diagnostic Radioisotopes Segment by Type

Tc-99m

F-18

Other

Diagnostic Radioisotopes Segment by Application

Oncology

Cardiology

Other

Diagnostic Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diagnostic Radioisotopes status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Diagnostic Radioisotopes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diagnostic Radioisotopes significant trends, drivers, influence factors in global and regions.

6. To analyze Diagnostic Radioisotopes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diagnostic Radioisotopes market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diagnostic Radioisotopes industry.

Chapter 3: Detailed analysis of Diagnostic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Diagnostic Radioisotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Diagnostic Radioisotopes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diagnostic Radioisotopes Industry Trends Table 2. Diagnostic Radioisotopes Industry Drivers Table 3. Diagnostic Radioisotopes Industry Opportunities and Challenges Table 4. Diagnostic Radioisotopes Industry Restraints Table 5. Global Diagnostic Radioisotopes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diagnostic Radioisotopes Revenue Share by Company (2021-2026) Table 7. Global Diagnostic Radioisotopes Sales Volume by Company (k units) & (2021-2026) Table 8. Global Diagnostic Radioisotopes Sales Volume Share by Company (2021-2026) Table 9. Global Diagnostic Radioisotopes Average Price (US$/unit) of Company (2021-2026) Table 10. Global Diagnostic Radioisotopes Company Ranking, (2024-2026) & (USD Million) Table 11. Global Diagnostic Radioisotopes Key Company Manufacturing Base & Headquarters Table 12. Global Diagnostic Radioisotopes Company, Product Type & Application Table 13. Global Diagnostic Radioisotopes Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Diagnostic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tc-99m Table 18. Significant Companies of F-18 Table 19. Significant Companies of Other Table 20. Global Diagnostic Radioisotopes Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Diagnostic Radioisotopes Sales Volume by Type (2021-2026) & (k units) Table 22. Global Diagnostic Radioisotopes Sales Volume by Type (2027-2032) & (k units) Table 23. Global Diagnostic Radioisotopes Sales Volume Share by Type (2021-2026) Table 24. Global Diagnostic Radioisotopes Sales Volume Share by Type (2027-2032) Table 25. Global Diagnostic Radioisotopes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Diagnostic Radioisotopes Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Diagnostic Radioisotopes Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Diagnostic Radioisotopes Sales Value Share by Type (2021-2026) Table 29. Global Diagnostic Radioisotopes Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Oncology Table 31. Significant Companies of Cardiology Table 32. Significant Companies of Other Table 33. Global Diagnostic Radioisotopes Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Diagnostic Radioisotopes Sales Volume by Application (2021-2026) & (k units) Table 35. Global Diagnostic Radioisotopes Sales Volume by Application (2027-2032) & (k units) Table 36. Global Diagnostic Radioisotopes Sales Volume Share by Application (2021-2026) Table 37. Global Diagnostic Radioisotopes Sales Volume Share by Application (2027-2032) Table 38. Global Diagnostic Radioisotopes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Diagnostic Radioisotopes Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Diagnostic Radioisotopes Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Diagnostic Radioisotopes Sales Value Share by Application (2021-2026) Table 42. Global Diagnostic Radioisotopes Sales Value Share by Application (2027-2032) Table 43. Global Diagnostic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Diagnostic Radioisotopes Sales by Region (2021-2026) & (k units) Table 45. Global Diagnostic Radioisotopes Sales Market Share by Region (2021-2026) Table 46. Global Diagnostic Radioisotopes Sales by Region (2027-2032) & (k units) Table 47. Global Diagnostic Radioisotopes Sales Market Share by Region (2027-2032) Table 48. Global Diagnostic Radioisotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Diagnostic Radioisotopes Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Diagnostic Radioisotopes Sales Value Share by Region (2021-2026) Table 51. Global Diagnostic Radioisotopes Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Diagnostic Radioisotopes Sales Value Share by Region (2027-2032) Table 53. Global Diagnostic Radioisotopes Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Diagnostic Radioisotopes Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Diagnostic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Diagnostic Radioisotopes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Diagnostic Radioisotopes Sales by Country (2021-2026) & (k units) Table 58. Global Diagnostic Radioisotopes Sales Market Share by Country (2021-2026) Table 59. Global Diagnostic Radioisotopes Sales by Country (2027-2032) & (k units) Table 60. Global Diagnostic Radioisotopes Sales Market Share by Country (2027-2032) Table 61. Global Diagnostic Radioisotopes Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Diagnostic Radioisotopes Sales Value Market Share by Country (2021-2026) Table 63. Global Diagnostic Radioisotopes Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Diagnostic Radioisotopes Sales Value Market Share by Country (2027-2032) Table 65. China Isotope & Radiation Company Information Table 66. China Isotope & Radiation Business Overview Table 67. China Isotope & Radiation Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio Table 69. China Isotope & Radiation Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Novartis Diagnostic Radioisotopes Product Portfolio Table 74. Novartis Recent Development Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Eli Lilly Diagnostic Radioisotopes Product Portfolio Table 79. Eli Lilly Recent Development Table 80. Dongcheng Company Information Table 81. Dongcheng Business Overview Table 82. Dongcheng Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Dongcheng Diagnostic Radioisotopes Product Portfolio Table 84. Dongcheng Recent Development Table 85. SIEMENS Company Information Table 86. SIEMENS Business Overview Table 87. SIEMENS Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. SIEMENS Diagnostic Radioisotopes Product Portfolio Table 89. SIEMENS Recent Development Table 90. Lantheus Company Information Table 91. Lantheus Business Overview Table 92. Lantheus Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Lantheus Diagnostic Radioisotopes Product Portfolio Table 94. Lantheus Recent Development Table 95. Jubilant Pharma Company Information Table 96. Jubilant Pharma Business Overview Table 97. Jubilant Pharma Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Jubilant Pharma Diagnostic Radioisotopes Product Portfolio Table 99. Jubilant Pharma Recent Development Table 100. GE Healthcare Company Information Table 101. GE Healthcare Business Overview Table 102. GE Healthcare Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. GE Healthcare Diagnostic Radioisotopes Product Portfolio Table 104. GE Healthcare Recent Development Table 105. Curium Pharma Company Information Table 106. Curium Pharma Business Overview Table 107. Curium Pharma Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Curium Pharma Diagnostic Radioisotopes Product Portfolio Table 109. Curium Pharma Recent Development Table 110. Cardinal Health Company Information Table 111. Cardinal Health Business Overview Table 112. Cardinal Health Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Cardinal Health Diagnostic Radioisotopes Product Portfolio Table 114. Cardinal Health Recent Development Table 115. Bracco Imaging Company Information Table 116. Bracco Imaging Business Overview Table 117. Bracco Imaging Diagnostic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Bracco Imaging Diagnostic Radioisotopes Product Portfolio Table 119. Bracco Imaging Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Diagnostic Radioisotopes Distributors List Table 123. Diagnostic Radioisotopes Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Diagnostic Radioisotopes Product Image Figure 2. Global Diagnostic Radioisotopes Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Radioisotopes Sales (2021-2032) & (k units) Figure 5. Global Diagnostic Radioisotopes Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Diagnostic Radioisotopes Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tc-99m Image Figure 10. F-18 Image Figure 11. Other Image Figure 12. Global Diagnostic Radioisotopes Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Diagnostic Radioisotopes Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Diagnostic Radioisotopes Sales Volume Share by Type (2021-2032) Figure 15. Global Diagnostic Radioisotopes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Diagnostic Radioisotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Diagnostic Radioisotopes Sales Value Share by Type (2021-2032) Figure 18. Oncology Image Figure 19. Cardiology Image Figure 20. Other Image Figure 21. Global Diagnostic Radioisotopes Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Diagnostic Radioisotopes Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Diagnostic Radioisotopes Sales Volume Share by Application (2021-2032) Figure 24. Global Diagnostic Radioisotopes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Diagnostic Radioisotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Diagnostic Radioisotopes Sales Value Share by Application (2021-2032) Figure 27. Global Diagnostic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Diagnostic Radioisotopes Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Diagnostic Radioisotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Diagnostic Radioisotopes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Diagnostic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 32. North America Diagnostic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Diagnostic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Diagnostic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Diagnostic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Diagnostic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Diagnostic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 38. South America Diagnostic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Diagnostic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Diagnostic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Diagnostic Radioisotopes Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Diagnostic Radioisotopes Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • F-18
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • China Isotope & Radiation
  • Novartis
  • Eli Lilly
  • Dongcheng
  • SIEMENS
  • Lantheus
  • Jubilant Pharma
  • GE Healthcare
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diagnostic Radioisotopes Sales Value (2021-2032)
  4. 1.2.2 Global Diagnostic Radioisotopes Sales Volume (2021-2032)
  5. 1.2.3 Global Diagnostic Radioisotopes Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Diagnostic Radioisotopes Market Dynamics
  1. 2.1 Diagnostic Radioisotopes Industry Trends
  2. 2.2 Diagnostic Radioisotopes Industry Drivers
  3. 2.3 Diagnostic Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Diagnostic Radioisotopes Industry Restraints
3 Diagnostic Radioisotopes Market by Company
  1. 3.1 Global Diagnostic Radioisotopes Company Revenue Ranking in 2025
  2. 3.2 Global Diagnostic Radioisotopes Revenue by Company (2021-2026)
  3. 3.3 Global Diagnostic Radioisotopes Sales Volume by Company (2021-2026)
  4. 3.4 Global Diagnostic Radioisotopes Average Price by Company (2021-2026)
  5. 3.5 Global Diagnostic Radioisotopes Company Ranking (2024-2026)
  6. 3.6 Global Diagnostic Radioisotopes Company Manufacturing Base and Headquarters
  7. 3.7 Global Diagnostic Radioisotopes Company Product Type and Application
  8. 3.8 Global Diagnostic Radioisotopes Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Diagnostic Radioisotopes Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Diagnostic Radioisotopes Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Diagnostic Radioisotopes Market by Type
  1. 4.1 Diagnostic Radioisotopes Type Introduction
  2. 4.1.1 Tc-99m
  3. 4.1.2 F-18
  4. 4.1.3 Other
  5. 4.2 Global Diagnostic Radioisotopes Sales Volume by Type
  6. 4.2.1 Global Diagnostic Radioisotopes Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Diagnostic Radioisotopes Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Diagnostic Radioisotopes Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Diagnostic Radioisotopes Sales Value by Type
  10. 4.3.1 Global Diagnostic Radioisotopes Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Diagnostic Radioisotopes Sales Value by Type (2021-2032)
  12. 4.3.3 Global Diagnostic Radioisotopes Sales Value Share by Type (2021-2032)
5 Diagnostic Radioisotopes Market by Application
  1. 5.1 Diagnostic Radioisotopes Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Diagnostic Radioisotopes Sales Volume by Application
  6. 5.2.1 Global Diagnostic Radioisotopes Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diagnostic Radioisotopes Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Diagnostic Radioisotopes Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Diagnostic Radioisotopes Sales Value by Application
  10. 5.3.1 Global Diagnostic Radioisotopes Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Diagnostic Radioisotopes Sales Value by Application (2021-2032)
  12. 5.3.3 Global Diagnostic Radioisotopes Sales Value Share by Application (2021-2032)
6 Diagnostic Radioisotopes Regional Sales and Value Analysis
  1. 6.1 Global Diagnostic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diagnostic Radioisotopes Sales by Region (2021-2032)
  3. 6.2.1 Global Diagnostic Radioisotopes Sales by Region: 2021-2026
  4. 6.2.2 Global Diagnostic Radioisotopes Sales by Region (2027-2032)
  5. 6.3 Global Diagnostic Radioisotopes Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Diagnostic Radioisotopes Sales Value by Region (2021-2032)
  7. 6.4.1 Global Diagnostic Radioisotopes Sales Value by Region: 2021-2026
  8. 6.4.2 Global Diagnostic Radioisotopes Sales Value by Region (2027-2032)
  9. 6.5 Global Diagnostic Radioisotopes Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Diagnostic Radioisotopes Sales Value (2021-2032)
  12. 6.6.2 North America Diagnostic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Diagnostic Radioisotopes Sales Value (2021-2032)
  15. 6.7.2 Europe Diagnostic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Diagnostic Radioisotopes Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Diagnostic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Diagnostic Radioisotopes Sales Value (2021-2032)
  21. 6.9.2 South America Diagnostic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Diagnostic Radioisotopes Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Diagnostic Radioisotopes Sales Value Share by Country, 2025 VS 2032
7 Diagnostic Radioisotopes Country-level Sales and Value Analysis
  1. 7.1 Global Diagnostic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diagnostic Radioisotopes Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Diagnostic Radioisotopes Sales by Country (2021-2032)
  4. 7.3.1 Global Diagnostic Radioisotopes Sales by Country (2021-2026)
  5. 7.3.2 Global Diagnostic Radioisotopes Sales by Country (2027-2032)
  6. 7.4 Global Diagnostic Radioisotopes Sales Value by Country (2021-2032)
  7. 7.4.1 Global Diagnostic Radioisotopes Sales Value by Country (2021-2026)
  8. 7.4.2 Global Diagnostic Radioisotopes Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Diagnostic Radioisotopes Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Diagnostic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Diagnostic Radioisotopes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China Isotope & Radiation
  2. 8.1.1 China Isotope & Radiation Company Information
  3. 8.1.2 China Isotope & Radiation Business Overview
  4. 8.1.3 China Isotope & Radiation Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio
  6. 8.1.5 China Isotope & Radiation Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Diagnostic Radioisotopes Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Diagnostic Radioisotopes Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Dongcheng
  20. 8.4.1 Dongcheng Company Information
  21. 8.4.2 Dongcheng Business Overview
  22. 8.4.3 Dongcheng Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dongcheng Diagnostic Radioisotopes Product Portfolio
  24. 8.4.5 Dongcheng Recent Developments
  25. 8.5 SIEMENS
  26. 8.5.1 SIEMENS Company Information
  27. 8.5.2 SIEMENS Business Overview
  28. 8.5.3 SIEMENS Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SIEMENS Diagnostic Radioisotopes Product Portfolio
  30. 8.5.5 SIEMENS Recent Developments
  31. 8.6 Lantheus
  32. 8.6.1 Lantheus Company Information
  33. 8.6.2 Lantheus Business Overview
  34. 8.6.3 Lantheus Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lantheus Diagnostic Radioisotopes Product Portfolio
  36. 8.6.5 Lantheus Recent Developments
  37. 8.7 Jubilant Pharma
  38. 8.7.1 Jubilant Pharma Company Information
  39. 8.7.2 Jubilant Pharma Business Overview
  40. 8.7.3 Jubilant Pharma Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jubilant Pharma Diagnostic Radioisotopes Product Portfolio
  42. 8.7.5 Jubilant Pharma Recent Developments
  43. 8.8 GE Healthcare
  44. 8.8.1 GE Healthcare Company Information
  45. 8.8.2 GE Healthcare Business Overview
  46. 8.8.3 GE Healthcare Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GE Healthcare Diagnostic Radioisotopes Product Portfolio
  48. 8.8.5 GE Healthcare Recent Developments
  49. 8.9 Curium Pharma
  50. 8.9.1 Curium Pharma Company Information
  51. 8.9.2 Curium Pharma Business Overview
  52. 8.9.3 Curium Pharma Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Curium Pharma Diagnostic Radioisotopes Product Portfolio
  54. 8.9.5 Curium Pharma Recent Developments
  55. 8.10 Cardinal Health
  56. 8.10.1 Cardinal Health Company Information
  57. 8.10.2 Cardinal Health Business Overview
  58. 8.10.3 Cardinal Health Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cardinal Health Diagnostic Radioisotopes Product Portfolio
  60. 8.10.5 Cardinal Health Recent Developments
  61. 8.11 Bracco Imaging
  62. 8.11.1 Bracco Imaging Company Information
  63. 8.11.2 Bracco Imaging Business Overview
  64. 8.11.3 Bracco Imaging Diagnostic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Bracco Imaging Diagnostic Radioisotopes Product Portfolio
  66. 8.11.5 Bracco Imaging Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diagnostic Radioisotopes Value Chain Analysis
  2. 9.1.1 Diagnostic Radioisotopes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diagnostic Radioisotopes Sales Mode & Process
  6. 9.2 Diagnostic Radioisotopes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diagnostic Radioisotopes Distributors
  9. 9.2.3 Diagnostic Radioisotopes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst